ANGEN.E — Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret A Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapFalling Star

Market Cap
TRY3.08bn
Enterprise Value
TRY2.73bn
Revenue
TRY268.82m

Annual income statement for Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret A, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Interim Report	Interim Report	Interim Report	ARS	ARS
Standards:	—	—	—	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	15.6	20.8	422	410	269
Cost of Revenue
Gross Profit	7.25	15.2	373	359	224
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	14.1	12.1	71.3	70.3	84.9
Operating Profit	1.46	8.78	350	340	184
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	0.35	6.92	360	462	340
Provision for Income Taxes
Net Income After Taxes	0.339	6.44	316	443	336
Minority Interest
Net Income Before Extraordinary Items
Net Income	0.864	6.99	293	433	330
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	0.864	6.99	293	433	330
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.008	0.064	2.67	2.86	1.5
Dividends per Share